RS20060437A - Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof - Google Patents

Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof

Info

Publication number
RS20060437A
RS20060437A RSP-2006/0437A RSP20060437A RS20060437A RS 20060437 A RS20060437 A RS 20060437A RS P20060437 A RSP20060437 A RS P20060437A RS 20060437 A RS20060437 A RS 20060437A
Authority
RS
Serbia
Prior art keywords
ezetimibe
preparation
higher primary
pharmaceutical compositions
primary alcohols
Prior art date
Application number
RSP-2006/0437A
Other languages
English (en)
Inventor
Rajesh JAIN
Kour Chand JINDAL
Sukhjeet Singh
Original Assignee
Panacea Boitec Ltd.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Boitec Ltd., filed Critical Panacea Boitec Ltd.,
Publication of RS20060437A publication Critical patent/RS20060437A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Obezbeđen je nov farmaceutski sastav koji sadrži smešu viših primarnih alifatičnih alkohola od 24 do 39 atoma ugljenika; bar još jednu različitu organsku komponentu izabranu od smola i pigmenata, ugljovodonika, estara, ketona i aldehida, i fenolnih jedinjenja i ezetimib, njegove soli, analoge ili njihove derivate, opciono sa farmaceutski prihvatljivim inertnim puniocima, i postupak za dobijanje takvog sastava. Takođe je obezbeđen metod za tretiranje i upotreba takvog sastava za smanjivanje abnormalnih lipidnih parametara vezanih za hiperlipidemiju.
RSP-2006/0437A 2004-01-20 2005-01-19 Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof RS20060437A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN103DE2004 2004-01-20
PCT/IN2005/000025 WO2005067903A1 (en) 2004-01-20 2005-01-19 Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof

Publications (1)

Publication Number Publication Date
RS20060437A true RS20060437A (en) 2008-11-28

Family

ID=34779371

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2006/0437A RS20060437A (en) 2004-01-20 2005-01-19 Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof

Country Status (9)

Country Link
US (1) US20070027218A1 (sr)
EP (1) EP1755573A1 (sr)
AP (1) AP2006003832A0 (sr)
AU (1) AU2005205166B8 (sr)
CA (1) CA2553985A1 (sr)
EA (1) EA010373B1 (sr)
RS (1) RS20060437A (sr)
WO (1) WO2005067903A1 (sr)
ZA (1) ZA200609584B (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
KR20080096851A (ko) * 2006-03-06 2008-11-03 테바 파마슈티컬 인더스트리즈 리미티드 에제티미베 조성물
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
WO2008061428A1 (fr) * 2006-11-24 2008-05-29 Fan Xian E Formulations pharmaceutiques, utilisation et élaboration du triacontanol
CN101190873B (zh) * 2006-11-24 2010-09-29 樊献俄 三十烷醇的制备方法
WO2009158328A1 (en) * 2008-06-23 2009-12-30 Trustees Of The University Of Pennsylvania Method for in vivo measurement of reverse cholesterol transport
EP2216016A1 (en) 2009-02-06 2010-08-11 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising ezetimibe
EP2468258A1 (en) * 2010-12-22 2012-06-27 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
CN104940153A (zh) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 一种治疗高血脂症的药物依折麦布组合物片剂
CN104958261A (zh) * 2015-08-05 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗心脑血管疾病的药物依折麦布组合物干混悬剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623667A (en) * 1985-06-28 1986-11-18 Richardson-Vicks Inc. Topical treatment of skin inflammatory disorders
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
US6596776B2 (en) * 1999-06-21 2003-07-22 Hauser, Inc. High molecular weight primary aliphatic alcohols obtained from natural products and uses thereof
US6225354B1 (en) * 1999-06-21 2001-05-01 Cholesterol Control Laboratories, Inc. High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
WO2002013824A1 (en) * 2000-08-17 2002-02-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2003241477A1 (en) * 2002-06-10 2003-12-22 Elan Pharma International, Ltd. Nanoparticulate polycosanol formulations and novel polycosanol combinations

Also Published As

Publication number Publication date
AU2005205166B2 (en) 2008-04-03
EA010373B1 (ru) 2008-08-29
WO2005067903A8 (en) 2005-11-03
EA200602202A1 (ru) 2007-04-27
AP2006003832A0 (en) 2006-12-31
CA2553985A1 (en) 2005-07-28
ZA200609584B (en) 2008-06-25
US20070027218A1 (en) 2007-02-01
AU2005205166A1 (en) 2005-07-28
EP1755573A1 (en) 2007-02-28
AU2005205166B8 (en) 2008-04-24
WO2005067903A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
RS20060437A (en) Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof
MX2022008066A (es) Compuestos triciclicos sustituidos.
MX2022006475A (es) Compuestos triciclicos sustituidos.
UA99361C2 (uk) ТРИАЗИНИ ЯК ІНГІБІТОРИ PІ3-КІНАЗИ І mTOR
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
WO2001098277A3 (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
SG10201806714PA (en) C7-fluoro substituted tetracycline compounds
EP2650293A8 (en) [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
WO2008064107A3 (en) 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
TW200716547A (en) Piperidin-4-yl-amide derivatives
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
TNSN08348A1 (en) Antibiotic compositions of modified release and process of production thereof
KR100792098B1 (ko) 혈청 콜레스테롤 저하제 또는 아테롬성 동맥경화증의 예방또는 치료제
MY153713A (en) A pharmaceutical composition comprising 3, 4-dihydro-3-methyl-4-oxoimidazo [5,1-d]-1,2,3,5-tetrazine-8-carboxylate
WO2007096740A3 (en) Novel cephalosporins
PT1583538E (pt) Utilização da 3-metoxi-pregnenolona para a preparação de um medicamento destinado a tratar as doenças neurodegenerativas
MX2024003738A (es) Formas solidas, composiciones farmaceuticas y preparacion de compuestos de eter macrociclico heteroaromatico.
WO2007054776A3 (en) Stilbene like compounds as novel hdac inhibitors
ZA200907956B (en) Novel carbamoyloxy arylalkanoyl arylpiperazine compound,pharmaceutical compositions comprising the compound and method for treating pain,anxiety and depression by administering the compound
RS20060436A (en) Pharmaceutical compositions comprising higher primary aliphatic alcohols and hmg coa reductase inhibitor and process of preparation thereof
RS20060042A (en) Novel compositions comprising higher primary alcohols and nicotinic acid and process of preparation thereof
WO2006069208A3 (en) Novel farnesyl protein transferase inhibitors as antitumor agents
MXPA05014127A (es) Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras.